Literature DB >> 12847639

The prevalence of hepatitis B carrier state in Khorassan province of Iran.

Ahmadshah Farhat1, Gholamreza Khademi, Shahriar J Mazlouman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12847639

Source DB:  PubMed          Journal:  Saudi Med J        ISSN： 0379-5284            Impact factor:   1.484


× No keyword cloud information.
  12 in total

1.  High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination.

Authors:  Mohammad J Ghabouli; Amir Hasan Sabouri; Naser Shoeibi; Sepideh Naghibzadeh Bajestan; H Baradaran
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006).

Authors:  Seyed Mohammad Alavi; Fatemeh Behdad
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

3.  Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan.

Authors:  M Sharif; Alireza Sherif; Mansour Sayyah
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01

4.  Prevalence of chronic hepatitis B infection in Iran: a review article.

Authors:  Jalal Poorolajal; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

5.  The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran.

Authors:  Farhad Fathimoghaddam; Mohammad Reza Hedayati-Moghaddam; Hamid Reza Bidkhori; Sanaz Ahmadi; Hamid Reza Sima
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

6.  Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Authors:  Mohammad Reza Ghadir; Mojtaba Belbasi; Akram Heidari; Mahboobeh Jandagh; Iman Ahmadi; Hosseinali Habibinejad; Alireza Kabiri; Amir Hossein Ghanooni; Abolfazl Iranikhah; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

7.  An economic analysis of premarriage prevention of hepatitis B transmission in Iran.

Authors:  Peyman Adibi; Mohammadreza Rezailashkajani; Delnaz Roshandel; Negar Behrouz; Shahin Ansari; Mohammad Hossein Somi; Saeed Shahraz; Mohammad Reza Zali
Journal:  BMC Infect Dis       Date:  2004-09-04       Impact factor: 3.090

8.  Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.

Authors:  Shahnaz Sali; Seyed Moayed Alavian; Graham R Foster; Hossein Keyvani; Leila Mehrnoosh; Navid Mohammadi
Journal:  Hepat Mon       Date:  2013-07-08       Impact factor: 0.660

9.  Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran.

Authors:  Hiva Saffar; Abolghasem Ajami; Mohammed Jafar Saffar; Jalil Shojaei; Maryam Sotudeh-Anvari; Kiarash Shams-Esfandabad; Ali Reza Khalilian
Journal:  Hepat Mon       Date:  2014-05-01       Impact factor: 0.660

Review 10.  Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Amir Almasi Hashiani; Mohammad Gholami Fesharaki; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-04-26       Impact factor: 0.660
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.